PREOPERATIVE CAPECITABINE, RADIATION AND BEVACIZUMAB IN RECTAL CANCER: FINAL RESULTS OF THE CRAB PHASE II TRIAL

被引:0
|
作者
Velenik, V. [1 ]
Ocvirk, J. [2 ]
Music, M. [3 ]
Bracko, M. [4 ]
Anderluh, F. [1 ]
Oblak, I. [1 ]
Edhemovic, I. [5 ]
Brecelj, E. [5 ]
Kropivnik, M. [3 ]
Omejc, M. [6 ]
机构
[1] Inst Oncol Ljubljana, Dept Radiat Oncol, Ljubljana, Slovenia
[2] Inst Oncol Ljubljana, Dept Med Oncol, Ljubljana, Slovenia
[3] Inst Oncol Ljubljana, Dept Radiol, Ljubljana, Slovenia
[4] Univ Med Ctr, Dept Pathol, Ljubljana, Slovenia
[5] Inst Oncol Ljubljana, Dept Surg, Ljubljana, Slovenia
[6] Univ Med Ctr, Dept Surg, Ljubljana, Slovenia
关键词
D O I
10.1016/S0167-8140(11)71190-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1068
引用
收藏
页码:S397 / S397
页数:1
相关论文
共 50 条
  • [1] FINAL SAFETY AND EFFICACY RESULTS OF A PHASE II TRIAL OF BEVACIZUMAB, CAPECITABINE, OXALIPLATIN, RADIATION RECTAL CANCER TRIAL (A-CORRECT)
    Kennecke, H.
    Berry, S.
    Wong, R.
    Zhou, C.
    Tankel, K.
    Easaw, J.
    Rao, S.
    Post, J.
    Hay, J.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 211 - 211
  • [2] BEVACIZUMAB IN PREOPERATIVE TREATMENT OF LOCALLY ADVANCED RECTAL CANCER -CRAB PHASE II TRIAL
    Velenik, Vaneja
    Ocvirk, Janja
    Music, Maja
    Bracko, Matej
    Anderluh, Franc
    Oblak, Irena
    Edhemovic, Ibrahim
    Brecelj, Erik
    Kropivnik, Mateja
    Omejc, Mirko
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : v130 - v130
  • [3] Neoadjuvant bevacizumab, capecitabine, and radiotherapy in locally advanced rectal cancer: Interim results of a phase II CRAB trial.
    Velenik, V.
    Ocvirk, J.
    Omejc, M.
    Music, M.
    Anderluh, F.
    Oblak, I.
    Edhemovic, I.
    Bracelj, E.
    Kropivnik, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Preoperative Radiation Therapy With Concurrent Capecitabine, Bevacizumab, and Erlotinib for Rectal Cancer: A Phase 1 Trial
    Das, Prajnan
    Eng, Cathy
    Rodriguez-Bigas, Miguel A.
    Chang, George J.
    Skibber, John M.
    You, Y. Nancy
    Maru, Dipen M.
    Munsell, Mark F.
    Clemons, Marilyn V.
    Kopetz, Scott E.
    Garrett, Christopher R.
    Shureiqi, Imad
    Delclos, Marc E.
    Krishnan, Sunil
    Crane, Christopher H.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 301 - 305
  • [5] Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results
    Czito, Brian G.
    Bendell, Johanna C.
    Willett, Christopher G.
    Morse, Michael A.
    Blobe, Gerard C.
    Tyler, Douglas S.
    Thomas, John
    Ludwig, Kirk A.
    Mantyh, Christopher R.
    Ashton, Jill
    Yu, Daohai
    Hurwitz, Herbert I.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (02): : 472 - 478
  • [6] Preoperative capecitabine, bevacizumab and IMRT for rectal cancer nongoing two stage phase II trial
    Ren, H.
    Jin, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S78 - S78
  • [7] Long term efficacy results from the phase II CRAB trial: Neoadjuvant bevacizumab, capecitabine and radiotherapy in locally advanced rectal cancer
    Velenik, V.
    Omejc, M.
    Ocvirk, J.
    Edhemovic, I.
    Anderluh, F.
    Oblak, I.
    But-Hadzic, J.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [8] Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
    Kathrin Dellas
    Thomas Höhler
    Thomas Reese
    Florian Würschmidt
    Erik Engel
    Claus Rödel
    Wolfgang Wagner
    Michael Richter
    Dirk Arnold
    Jürgen Dunst
    [J]. Radiation Oncology, 8
  • [9] Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
    Dellas, Kathrin
    Hoehler, Thomas
    Reese, Thomas
    Wuerschmidt, Florian
    Engel, Erik
    Roedel, Claus
    Wagner, Wolfgang
    Richter, Michael
    Arnold, Dirk
    Dunst, Juergen
    [J]. RADIATION ONCOLOGY, 2013, 8
  • [10] Phase I Trial of Preoperative Radiation Therapy with Concurrent Capecitabine, Bevacizumab, and Erlotinib for Rectal Adenocarcinoma
    Das, P.
    Eng, C.
    Rodriguez-Bigas, M. A.
    Chang, G. J.
    Skibber, J. M.
    Maru, D. M.
    Munsell, M. F.
    Clemons, M. V.
    Krishnan, S.
    Crane, C. H.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S96 - S97